Loading interface...

Glimy 1 MG Tablet

Manufactured byDr. Reddys Laboratories Ltd.
ContainsGlimepiride
Description

Glimy 1 MG Tablet is a long-acting oral anti-diabetic which lower the blood sugar level. It is used only in patients diagnosed with Type II Diabetes. It may be used along with Insulin or other medicines in order to achieve better control over the blood sugar levels. This medicine, when taken along with a controlled diet and regular exercise routine, may give better results.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now

Side effects

Major & minor side effects for Glimy 1 MG Tablet

  • Hypoglycemia
  • Dizziness
  • Headache
  • Nausea
  • Asthenia
  • Flu like symptoms
  • Allergic skin reaction
  • Elevated liver enzymes
  • Anemia
  • Jaundice
  • Weight gain

Uses of Glimy 1 MG Tablet

What is it prescribed for?

  • Type II Diabetes Mellitus
Read More
Concerns

Commonly asked questions

  • Onset of action
    The effect of this medicine can be observed within an hour of oral administration. However, it takes 2-4 hours for the medicine to reach its peak effect.
  • Duration of effect
    The effect of this medicine lasts for an average of 24 hours.
  • Safe with alcohol?
    Consumption of alcohol in large quantities is not recommended when you are taking Glimy 1 MG Tablet for controlling blood sugar levels. It is recommended to reduce the alcohol intake so that the incidence of adverse effects can be reduced. Symptoms of both reduced or elevated blood sugar levels should be reported to the doctor immediately.
  • Is it habit forming?
    No habit forming tendencies were reported
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

This medicine is not recommended for use by patients with a known history of allergy to Glimy 1 MG Tablet or any other agents belonging to the Sulphonamide class of antidiabetic medicines.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Hypoglycemia

Glimy 1 MG Tablet can cause moderate to severe lowering of blood glucose levels. The risks are even greater in elderly, malnourished, people with kidney and pituitary gland disorders. You should report any such incidence to the doctor. Carry a reliable source of glucose like sugar candy to counteract the effect of low blood sugar levels.

Stress

Use of this medicine should be discontinued in patients exposed to stressful conditions such as a fever, trauma, surgeries, or accidents since it may not be effective in controlling blood sugar levels in these conditions. Replacement with a suitable alternative should be considered under your doctor's supervision.

Liver/Kidney disease

Glimy 1 MG Tablet should be administered with caution in patients with a disorder of kidney and/or liver. Suitable dosage adjustments and monitoring of blood sugar levels are necessary in such cases.

Allergy

This medicine is not recommended for use in patients with known history of allergy to Glimy 1 MG Tablet or other drugs belonging to the Sulphonamide class of antidiabetic medicines.

Fluid Retention

Glimy 1 MG Tablet can cause retention of fluid in some cases that may lead to severe and harmful effects on the body.

Heart Disease

Glimy 1 MG Tablet can cause heart-related complications especially if you have an active disease of the heart.

Weight gain

This medicine may cause a mild to moderate weight gain in some patients.

Hemolytic Anemia

Glimy 1 MG Tablet can cause Hemolytic Anemia if you have a rare genetic disorder called G6PD Deficiency.

Alcohol use

Consumption of alcohol is not recommended while on treatment with Glimy 1 MG Tablet due to the increased risk of severe adverse effects.

Photo-sensitivity

Glimy 1 MG Tablet may cause allergic skin reactions when exposed to the sun. Take precautionary skin protection measures while going out into sun if you are taking this medicine.

Change of drugs

You may experience some temporary side effects if there is a change in current medication. This overlapping effect is because of the change from one medicine to another. Regular monitoring of blood sugar levels might be required in these cases.

Missed Dose

The missed dose can be taken as soon as you remember. If it is time for the next dosage then the missed dose can be skipped.

Overdose

It is recommended to discontinue the medication and contact your doctor immediately if an overdose is suspected. Symptoms like dizziness, confusion, increased heartbeat, tremor and sweating after taking the medication should be reported immediately.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol in large quantities is not recommended when you are taking Glimy 1 MG Tablet for controlling blood sugar levels. It is recommended to reduce the alcohol intake so that the incidence of adverse effects can be reduced. Symptoms of both reduced or elevated blood sugar levels should be reported to the doctor immediately.
Interaction with Medicine

Diclofenac

Fluconazole

Gatifloxacin

Miconazole

Rifampicin

Colesevelam

Disease interactions

Heart disease

This medicine should be administered with extreme caution in patients suffering from heart diseases or diseases of the blood vessels due to the increased risk of severe adverse effects. Close monitoring of heart function and vital signs is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Kidney disease

Glimy 1 MG Tablet should be administered with extreme caution in patients with impaired kidney function. It is advised to consult your doctor to make a suitable adjustment in dosage and/or time-interval between two dosages.

Liver disease

Glimy 1 MG Tablet should be administered with extreme caution in patients with impaired liver function. It is advised to consult your doctor to make a suitable adjustment in dosage and/or time-interval between two dosages.

Hypoglycemia

Glimy 1 MG Tablet should be administered with caution in if you are prone to having episodes of low blood sugar especially in diabetics who are also malnourished or those receiving Beta-blocker drugs such as Metoprolol and Propranolol.

Hemolytic Anemia/G6PD Deficiency

This medicine is not recommended for use in patients with a history of Hemolytic Anemia or patients with G6PD deficiency due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions

Elevated ALT

You should consult the doctor about the use of Glimy 1 MG Tablet if a liver function test is to be performed. Use of this medicine may produce a false result.
Take Glimy 1 MG Tablet as directed by your doctor. Follow the instructions mentioned on the label. The medicine should be taken orally with breakfast or the first meal of the day. Adequate amount of water should be consumed while taking this medication.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

May cause sleepiness

How it works
It increases the secretion of insulin from the pancreas and also regulates the release of glucose from the liver.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Sulfonylureas

Schedule

Schedule H

DailyMed - Glimepiride tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 24 February 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60e9397e-83b9-489e-9683-6f87e458bbaa

[Internet]. 2017 [cited 24 February 2017]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020496s021lbl.pdf

Glimepiride - DrugBank [Internet]. Drugbank.ca. 2017 [cited 24 February 2017]. Available from:

https://www.drugbank.ca/drugs/DB00222

Glimepiride | C24H34N4O5S - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 24 February 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/3476#
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 10 May 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.